The SDHA gene plays a crucial role in the mitochondrial respiratory chain, specifically in Complex II, which is vital for energy production within cells. Deficiencies in Complex II can lead to a range of serious genetic disorders, including Leigh syndrome, cardiomyopathy, and mitochondrial encephalomyopathy. These conditions can manifest as neurological deficits, muscle weakness, heart problems, and metabolic disturbances.
The SDHA Gene Mitochondrial Respiratory Chain Complex II Deficiency Genetic Test is a specialized diagnostic tool used to identify mutations in the SDHA gene. By analyzing an individual's DNA, this test can confirm or rule out the presence of genetic abnormalities affecting Complex II, assisting in the diagnosis, management, and treatment planning for affected patients.
This test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The cost of the test is 4400 AED. DNA Labs UAE utilizes state-of-the-art technology and employs a team of genetic experts to ensure accurate and reliable results. This test is crucial for families with a history of mitochondrial or metabolic disorders, providing essential information for genetic counseling and decision-making regarding family planning.
The TIMM21 gene plays a crucial role in the proper functioning of the mitochondrial respiratory chain, which is essential for energy production in cells. Mutations in the TIMM21 gene can lead to mitochondrial respiratory chain diseases, which are a group of disorders that affect the mitochondria's ability to produce energy efficiently. These diseases can have a wide range of symptoms and can affect multiple organs and systems in the body.
To diagnose and understand the specific genetic mutations in the TIMM21 gene, genetic testing is available. The TIMM21-related genetic test is a specialized diagnostic tool designed to identify mutations in the TIMM21 gene that may be responsible for mitochondrial respiratory chain diseases. This test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment options.
The test is available at DNA Labs UAE, a leading facility specializing in genetic and molecular diagnostics. The cost of the TIMM21-related genetic test is 4400 AED. This investment in testing can provide essential information for affected individuals and their families, enabling them to make informed decisions about their health and treatment plans.
The ECHS1 gene encodes the mitochondrial enzyme short-chain enoyl-CoA hydratase 1, which plays a critical role in the metabolism of fatty acids and amino acids. Mutations in the ECHS1 gene can lead to a deficiency in this enzyme, resulting in a range of metabolic disorders. These disorders are often characterized by developmental delay, epilepsy, lactic acidosis, and cardiomyopathy, among other symptoms. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
The genetic test for ECHS1 gene mitochondrial short-chain enoyl-CoA hydratase 1 deficiency is a specialized diagnostic tool designed to detect mutations in the ECHS1 gene. This test is vital for confirming the diagnosis, understanding the disease's progression, and guiding treatment options. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory to identify any mutations in the ECHS1 gene.
In the UAE, this specific genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the region. The cost of the test is set at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring accurate and reliable results. This test is an important resource for families and individuals at risk of or showing symptoms of ECHS1 deficiency, providing them with essential information for managing the condition.
The ANO5 Gene Miyoshi Muscular Dystrophy Type 3 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the ANO5 gene, which are linked to the development of Miyoshi Muscular Dystrophy Type 3 (MMD3). This form of muscular dystrophy is a rare genetic disorder characterized by muscle weakness and atrophy, primarily affecting the muscles of the lower limbs. The test plays a crucial role in confirming the diagnosis, enabling early intervention, and allowing for better management of the condition. Priced at 4400 AED, the test involves analyzing the patient's DNA to identify any genetic alterations in the ANO5 gene, providing valuable information for affected individuals and their families regarding the prognosis and potential genetic counseling needs. DNA Labs UAE, known for its advanced genetic testing capabilities, offers this comprehensive service, ensuring accuracy and reliability in the results.
DYSF Gene Miyoshi Myopathy Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the DYSF gene, which are responsible for Miyoshi Myopathy. Miyoshi Myopathy is a type of muscular dystrophy characterized by muscle weakness and atrophy, primarily affecting the distal muscles of the legs and arms. This genetic disorder is inherited in an autosomal recessive manner, meaning that two copies of the mutated gene, one from each parent, are required for the condition to manifest.
The test is performed at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability. By analyzing a patient's DNA sample, usually obtained through a blood draw, the test can pinpoint specific mutations in the DYSF gene, confirming a diagnosis of Miyoshi Myopathy. This is crucial for the development of a tailored treatment plan and for providing genetic counseling to affected individuals and their families.
The cost of the DYSF Gene Miyoshi Myopathy Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers invaluable insights into the genetic basis of the condition, facilitating early intervention and management strategies that can significantly improve the quality of life for those affected.
The PIGT Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 3 (MCAHS3) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PIGT gene, which can lead to the development of MCAHS3. This syndrome is a rare genetic disorder characterized by a spectrum of symptoms including multiple congenital anomalies, muscle hypotonia (reduced muscle tone), and seizures, among others. The genetic test plays a crucial role in the early diagnosis and management of the syndrome, allowing for timely intervention and support for affected individuals.
The test is conducted through a detailed analysis of the patient's DNA to detect abnormalities in the PIGT gene that are indicative of MCAHS3. This is crucial for understanding the specific genetic alterations in an individual, which can help in tailoring personalized treatment and management plans. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the PIGT gene.
By opting for this genetic test at DNA Labs UAE, patients and their families can gain valuable insights into the genetic underpinnings of the syndrome, facilitating informed decisions regarding care and management. It is an important step towards improving the quality of life for individuals with MCAHS3 through targeted interventions and support.
The NFU1 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 1 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the NFU1 gene, which are associated with Multiple Mitochondrial Dysfunctions Syndrome Type 1 (MMDS1). MMDS1 is a rare genetic disorder characterized by a wide range of symptoms, including developmental delay, neurological deterioration, and metabolic abnormalities, stemming from impaired mitochondrial function.
Mitochondria are known as the powerhouses of the cell, and their dysfunction can lead to severe and often life-threatening conditions. The NFU1 gene plays a crucial role in the biosynthesis of iron-sulfur (Fe-S) clusters, essential components for mitochondrial energy production. Mutations in the NFU1 gene disrupt this process, leading to the symptoms observed in MMDS1.
The test conducted at DNA Labs UAE involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific mutations in the NFU1 gene. This genetic test is critical for early diagnosis, which can significantly influence the management and treatment strategies for affected individuals. Early intervention may include dietary modifications, supplements, and supportive therapies aimed at improving quality of life and mitigating the progression of symptoms.
In summary, the NFU1 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 1 Genetic Test is a valuable diagnostic tool for identifying the genetic cause of MMDS1, facilitating early and effective management of the disorder. Offered at DNA Labs UAE for 4400 AED, this test represents a crucial step towards personalized care for individuals with this rare mitochondrial condition.
The BOLA3 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the BOLA3 gene. These mutations are known to cause Multiple Mitochondrial Dysfunctions Syndrome Type 2 (MMDS2), a rare genetic disorder characterized by a wide range of clinical symptoms, including severe metabolic abnormalities, developmental delay, and lactic acidosis. The condition stems from impaired function of the mitochondrial respiratory chain, crucial for energy production in cells.
The test is conducted using a sample of the patient's blood or saliva, from which DNA is extracted and analyzed for specific genetic alterations in the BOLA3 gene. This precise approach enables healthcare providers to make an accurate diagnosis, essential for managing the condition effectively.
Priced at 4400 AED, the test is a significant investment in understanding and addressing this complex disorder. Conducted at the state-of-the-art facilities of DNA Labs UAE, patients can expect a high standard of accuracy and reliability in their test results, providing essential information for the management of MMDS2. This genetic test is a crucial tool for families seeking answers to unexplained symptoms related to mitochondrial dysfunction, offering a pathway towards tailored treatment and management plans.
The IBA57 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 3 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the IBA57 gene. These mutations are associated with Multiple Mitochondrial Dysfunctions Syndrome Type 3 (MMDS3), a rare genetic disorder that impacts mitochondrial function, leading to a range of severe clinical manifestations, including neurological and developmental abnormalities.
This test is crucial for individuals suspected of having MMDS3, as it provides a definitive diagnosis by analyzing the genetic makeup of the patient for specific mutations in the IBA57 gene. Early and accurate diagnosis is essential for managing symptoms, potential interventions, and genetic counseling for affected families.
DNA Labs UAE, a leading facility in genetic testing, offers this comprehensive genetic test at a cost of 4400 AED. The test is conducted using advanced genomic technologies to ensure high accuracy and reliability of results, making it a valuable tool for affected individuals and their families seeking answers and options for managing this complex condition.
The ISCA2 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 4 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the ISCA2 gene. These mutations are associated with Multiple Mitochondrial Dysfunctions Syndrome Type 4, a rare genetic condition that affects mitochondrial function, leading to a range of symptoms including developmental delay, muscle weakness, and metabolic abnormalities. The test is crucial for early diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic alterations in the ISCA2 gene. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the genetic diagnosis and personalized medicine for patients with suspected mitochondrial disorders.
